The day eye medicine tycoon shareholder proposal self waiver

Securities Times reporter Lee Big shareholder abstained from voting on his proposal, this scene happened in Tianmu Pharmaceutical (600671, shares) (600671). June 28, the TIANMU pharmaceutical industry held the 2012 annual shareholder meeting to consider 9 motions.　　Among them, the bill on the exemption of part of the directors of the company was not approved by the general meeting of shareholders, the bill agreed to 0 shares, against 22.0262 million shares of the General Assembly voting shares of the total number of 40.47%, abstained shares 32.4004 million shares of the General Assembly voting shares of the total number of 59.53%.　　From the company's ownership structure, shareholders and announcements, we can see that: abstention mainly from the major shareholders of the Great Wall state and related people; the main objections to the above proposals include the former owner of Hangzhou Hyundai Joint Investment Co., Ltd., the early Han Yu. The timing of the general meeting was established in early June and only 7 routine motions were announced at the time. June 18, the Great Wall of China submitted an interim proposal to the General Assembly of the company to exempt Pan Yue Vice Chairman, director of the Office, to remove the director of the party Bao Kang, to draw Fangli and other 7 candidates for the board of Directors;　　However, Pan Yuedong suddenly on June 27 to resign the company director, Vice chairman of the office. The announcement pointed out that, as a result of the resignation of Pan Yuedong, "on the exemption of the company part of the director of the position of the motion" changes in the objective conditions, through the full communication between the shareholders, the Great Wall Guo Hui to withdraw the motion, no longer to the General Assembly of the shareholders to remove the director However, the proposal stipulated in the notice of the general meeting shall not be cancelled because of the provisions of the Articles of Incorporation ". To avoid breaking the rules, the shareholders agreed to continue voting on the motion. Accordingly, the Great Wall of China eventually abstained from voting on its own motion.　　Fang Baokang's directorship has also been retained as a result of the motion. Prior to that, the Great Wall of China said in the proposal, "because some of the company directors have been unable to represent shareholders, so the General Assembly to remove Pan Yue East Vice Chairman, Director of the post, to exempt Fang Baokang director." However, Pan Yue East resignation but let Fang Bao Kang Instant become can represent the shareholder, the mystery, only the Tianmu medicine itself clear.